Cite
Nose-to-brain delivery of simvastatin mediated by chitosan-coated lipid-core nanocapsules allows for the treatment of glioblastoma in vivo.
MLA
Bruinsmann, Franciele Aline, et al. “Nose-to-Brain Delivery of Simvastatin Mediated by Chitosan-Coated Lipid-Core Nanocapsules Allows for the Treatment of Glioblastoma in Vivo.” International Journal of Pharmaceutics, vol. 616, Mar. 2022, p. 121563. EBSCOhost, https://doi.org/10.1016/j.ijpharm.2022.121563.
APA
Bruinsmann, F. A., de Cristo Soares Alves, A., de Fraga Dias, A., Lopes Silva, L. F., Visioli, F., Raffin Pohlmann, A., Figueiró, F., Sonvico, F., & Stanisçuaski Guterres, S. (2022). Nose-to-brain delivery of simvastatin mediated by chitosan-coated lipid-core nanocapsules allows for the treatment of glioblastoma in vivo. International Journal of Pharmaceutics, 616, 121563. https://doi.org/10.1016/j.ijpharm.2022.121563
Chicago
Bruinsmann, Franciele Aline, Aline de Cristo Soares Alves, Amanda de Fraga Dias, Luiz Fernando Lopes Silva, Fernanda Visioli, Adriana Raffin Pohlmann, Fabrício Figueiró, Fabio Sonvico, and Silvia Stanisçuaski Guterres. 2022. “Nose-to-Brain Delivery of Simvastatin Mediated by Chitosan-Coated Lipid-Core Nanocapsules Allows for the Treatment of Glioblastoma in Vivo.” International Journal of Pharmaceutics 616 (March): 121563. doi:10.1016/j.ijpharm.2022.121563.